Shanghai Freemen and NXT USA Launch Novel Digestive Health Solution
10.27.22
New human study shows Digexin improves digestion while enhancing mood.
Booth #7111
NXT USA, a new company developing unique nutraceutical solutions, and global ingredient supplier Shanghai Freemen are launching Digexin together at SupplySide West.
Backed by a double-blind, placebo-controlled human study pending publication, Digexin is validated to improve digestion and enhance mood and other quality of life measures, according to the companies. A second larger clinical trial is underway to further demonstrate Digexin’s benefits.
“Digexin is a new approach in the digestive category, promoting regularity while also promoting mood, sleep, and stress support,” said Eric Anderson, managing director, NXT USA. “We are excited to partner with Shanghai Freemen to expand the market for consumers that desire both benefits. For many people, this can be the difference between a good day, and a not-so-good day.”
Hanks Li, president of Shanghai Freemen Americas commented: “We are excited to be bringing Digexin to market with an accomplished partner like NXT USA. As our first proprietary ingredient, we see substantial potential in Digexin and its clinically validated benefits. This is an important step as we expand our capabilities to meet evolving customer needs,” he said, adding, “We will initially offer Digexin in the U.S. where consumers understand the significant health and wellness role of the gut-brain axis. But with 25 years’ experience and offices in the U.S., EU, China, Australia, and Japan, we are optimistic for broader success.”
The clinical study showed tangible results across multiple measures. Compared to placebo, the benefits demonstrated by Digexin included:
“Our first human study produced the statistically significant results in healthy subjects we anticipated, so we are even more excited about the larger clinical trial currently underway to confirm and validate Digexin’s benefits,” Anderson said. “For consumers not satisfied with existing gut health products due to efficacy, side effects, or simply needing additional action, Digexin provides a new choice.”
NXT USA, a new company developing unique nutraceutical solutions, and global ingredient supplier Shanghai Freemen are launching Digexin together at SupplySide West.
Backed by a double-blind, placebo-controlled human study pending publication, Digexin is validated to improve digestion and enhance mood and other quality of life measures, according to the companies. A second larger clinical trial is underway to further demonstrate Digexin’s benefits.
“Digexin is a new approach in the digestive category, promoting regularity while also promoting mood, sleep, and stress support,” said Eric Anderson, managing director, NXT USA. “We are excited to partner with Shanghai Freemen to expand the market for consumers that desire both benefits. For many people, this can be the difference between a good day, and a not-so-good day.”
Hanks Li, president of Shanghai Freemen Americas commented: “We are excited to be bringing Digexin to market with an accomplished partner like NXT USA. As our first proprietary ingredient, we see substantial potential in Digexin and its clinically validated benefits. This is an important step as we expand our capabilities to meet evolving customer needs,” he said, adding, “We will initially offer Digexin in the U.S. where consumers understand the significant health and wellness role of the gut-brain axis. But with 25 years’ experience and offices in the U.S., EU, China, Australia, and Japan, we are optimistic for broader success.”
The clinical study showed tangible results across multiple measures. Compared to placebo, the benefits demonstrated by Digexin included:
- Reduced constipation symptoms;
- Improved sense of complete evacuation;
- Better quality of sleep; and
- Improved quality of life through significantly reduced physical and psychological discomfort, worries, and concerns.
“Our first human study produced the statistically significant results in healthy subjects we anticipated, so we are even more excited about the larger clinical trial currently underway to confirm and validate Digexin’s benefits,” Anderson said. “For consumers not satisfied with existing gut health products due to efficacy, side effects, or simply needing additional action, Digexin provides a new choice.”
